This is what precarity feels like: Early Career Researchers and “cruel optimism”

Originally posted on All the Single Writing Ladies:
The AHRC defines of “Early Career Researchers” (ECRs) as individuals “within eight years of the award of their PhD […] or within six years of their first academic appointment.” In practice, ECRs are a highly heterogeneous demographic comprising individuals in a range of employment circumstances, from hourly…

Radical Health

Bill Booth kindly invited me on to his podcast to discuss health and medicine. Bill is one of the founders of Radical Americas, an academic network for scholars and activists with interests in radicalism in the Western Hemisphere. Here I spoke with the #radical @WilliamABooth about health, medicine, science and death! Have a listen ifContinue reading “Radical Health”

New Editors at Social History of Alcohol and Drugs

The ADHS is pleased to announce that the editorship of its journal, *The Social History of Alcohol and Drugs*, will be taken over by Prof. Nancy D. Campbell (Rensselaer Polytechnic Institute), Prof. David Herzberg (Buffalo) and Dr. Lucas Richert (Strathclyde). The society would also like to express its gratitude for the work that outgoing editor, […]Continue reading “New Editors at Social History of Alcohol and Drugs”

ADHS 2019

The ADHS is excited to announce that its next bi-annual conference will be held between 12 and 15 June 2019, at the David F. Musto Center for Drug Policy Studies, Shanghai University, China. The conference will be organised by Prof. Jim Mills, of the University of Strathclyde and Prof. Yong-an Zhang of Shanghai University, who […]Continue reading “ADHS 2019”

Connect with ADHS at AHA 2018 in Washington, D.C.! — Points: The Blog of the Alcohol & Drugs History Society

Today, historians begin descending upon wintry Washington, D.C., for the 2018 meeting of the American Historical Association. AHA is the largest annual gathering for such professionals and their affiliated societies. Among those represented again this year is the Alcohol and Drugs History Society, with two panels of original research and one roundtable discussion. The date, […]Continue reading “Connect with ADHS at AHA 2018 in Washington, D.C.! — Points: The Blog of the Alcohol & Drugs History Society”

Big Pharma Round-Up V (#Cannabis edition)

Any of this stock market record due to Big Pharma boost from Jeff Sessions new memo against people's right to legal cannabis? https://t.co/HQotfSGzAl — Martha Densmore (@Acubody) January 4, 2018 Big Pharma wanted to sell more opioids. Then this happened..#opioidcrisis #opioid @conradhackett pic.twitter.com/rpHxGDeytW Alternatives, such as cannabis *cannot* overdose and are *way less* addictive —Continue reading “Big Pharma Round-Up V (#Cannabis edition)”

Sara Pascoe on #Resolutions

👇🏼https://t.co/rW3oPeYO8d — Sara Pascoe (@sarapascoe) January 3, 2018 Sara Pascoe on resolutions https://www.theguardian.com/commentisfree/2018/jan/02/we-should-all-pick-achievable-resolutions-get-through-three-days-of-dry-january-and-youre-a-hero-to-me For me it was a slang phrase that ruined it. A man was talking, and I was listening politely because he was a friend of a friend. “Friend of a friend” is an excellent expression, it passively clarifies: “I know them …Continue reading “Sara Pascoe on #Resolutions”

CFP. Temperance and Teetotalism.

RADICAL TEMPERANCE: SOCIAL CHANGE AND DRINK, FROM TEETOTALISM TO DRY JANUARY UNIVERSITY OF CENTRAL LANCASHIRE, PRESTON, 28-29 JUNE 2018 FEATURING KEYNOTE ADDRESSES BY: Professor Scott Martin, Bowling Green University, Ohio Professor Betsy Thom, Middlesex University This conference seeks to explore the radical aspects of the avoidance of alcohol. We are looking for contributions […] via FromContinue reading “CFP. Temperance and Teetotalism.”

To publish…

I wrote about Lambert Publishers last month. And they’ve come back at me again. They want to publish an article of mine. Lambert is, of course, a ‘predatory publisher,’ and the company is all about cashing in on other’s work. Here’s what they wrote me earlier this month. Again, I went to school for aContinue reading “To publish…”

Big Pharma Round-Up III

A lot happened in the world of pharmaceuticals this year. The opioid crisis worsened. The FDA got a new chief. There were big failures and prices reemerged as a major issue. Industry needed to contend with the new Trump administration and gene therapy ‘came of age.’ By the way, here is one year in reviewContinue reading “Big Pharma Round-Up III”